Forgot password? Sign Up

Blogs about: Avandia

Featured Blog

Could “No See” docs be doing a disservice to patients?

srxa wrote 1 day ago: One of the biggest challenges facing any Pharma rep is the increasing number of  doctors who won’t s … more →

Tags: Clinical Research, diabetes, drugs, Health Outcomes, Medical Education, Pharmaceutical Industry, physicians, SRxA, Word on Health

Who's running the show in industry-sponsored drug trials?8 comments

Carolyn Thomas wrote 2 weeks ago: There is strong evidence that medical researchers’ financial ties to their industry funders may dire … more →

Tags: Big Pharma, In the research lab, Big Pharma conflict of interest, Dr. An-Wen Chan, Dr. Mohammed Hassan Murad, GlaxoSmithKline

Treating Teens With Type 2 Diabetes Gets Tricky

matthewbuettner wrote 3 weeks ago: AURORA, Colo. (CBS4) – The fight against Type 2 diabetes just got more urgent. That’s be … more →

Tags: health, Local, News, Syndicated Local, Dr. Philip Zeitler, Metformin, The Children's Hospital, Type 2 Diabetes

Type 2 Diabetes Is Tougher to Treat in Kids and Teens1 comment

Alexandra Sifferlin wrote 3 weeks ago: Type 2 diabetes, the kind linked with obesity, progresses much faster and is harder to treat in chil … more →

Tags: diabetes, Medicine, Childhood Obesity, Metformin, obesity, Treatment, Type 2 Diabetes

Nissen Says Its Time To Pull Avandia Off The Market: Video

truthman30 wrote 4 weeks ago: http://www.youtube.com/watch?v=FcBOhivfzOo   Published on Mar 23, 2012 by Bloomberg Feb. 22 (Bloombe … more →

Tags: GSK, Side Effects, Steve Nissen, diabetes, Glaxo, GlaxoSmithKline, Heart Attacks

GSK Videos on YouTube

truthman30 wrote 1 month ago: Some interesting GSK related video’s popping up on YouTube… “The Key with Avandia … more →

Tags: SSRI, chemical imbalance, GSK, Seroxat, Psychiatry, Side Effects, Steve Nissen, Glaxo, GlaxoSmithKline

Whistleblower Sues Takeda Pharmaceutical And Claims They Intentionally Underreported Actos Problems

Sadaka Associates wrote 2 months ago: Did Takeda Pharmaceutical not take reports of heart failure seriously in Actos patients? That’ … more →

Tags: Drug Safety News, Actos bladder cancer, actos, lawsuits, Takeda Pharmaceuticals, glaskosmithkline, Heart Failure, Type 2 Diabetes, Whistleblower

Global Diabetes Market Review 2008 & World Top Ten Diabetes Drugs

krishan-maggon wrote 2 months ago: This site complies with the HONcode standard for trustworthy health information: verify here. Search … more →

Tags: blockbuster drugs, health, Review, Pharmaceutical, diabetes, R&D, Medicine, Biologics, New Drugs

Limbaugh, Stewart, Maher and the like have come to symbolize lazy journalism . . . so why do we listen?2 comments

piblogger wrote 2 months ago: What’s amazing about the Limbaugh comments – in fact the discussion in general, regardin … more →

Tags: Commentary/Article, Health Care & Medicine, Politics, Medicaid, anti-psychotic drugs, Limbaugh, Stewart, Maher, Fluke

GSK To Settle 20,000 Avandia Heart Attack Lawsuits

Sadaka Associates wrote 3 months ago: About 20,000 former Avandia drug users have finally gotten the news they had been desperately waitin … more →

Tags: Drug Safety News, diabetes, GlaxoSmithKline, Heart Attacks, death, Stroke, mediation, Settlement, GSK

8 drugs doctors won't take5 comments

Dr. Eowyn wrote 3 months ago: Poojah writes for Refreshing News, January 21, 2012, on the eight medications that “doctors wo … more →

Tags: Health Care, visine eye drops, Pseudoephedrine, prilosec, Nexium, ketek, celebrex, advair

GSK pays Damages of $3,000,000,000 (Three Billion) to settle defective drug Avandia Cases3 comments

truthman30 wrote 3 months ago: http://www.bloomberg.com/news/2012-02-01/glaxosmithkline-agrees-to-settle-20-000-more-avandia-cases- … more →

Tags: GSK, Side Effects, Glaxo, Heart Attacks, Pharmaceutical Industry, Defective, Damage

Susan Levin: Paula Deen’s new mantra won’t beat diabetes epidemic1 comment

Editorial Pages wrote 4 months ago: It’s not the sweet tea. It’s the butter, the beef and the bacon. Paula Deen has finally confirmed ru … more →

Tags: Opinion, vegetarian, opinion 2, Op-Ed, Column, diabetes, paual deen, Type 2, Susan Levin

Delay in approval of diabetes drug...just a delay?

doctorinsulin wrote 4 months ago: The Food and Drug Administration in the US has delayed granting approval for a new class of anti-dia … more →

Tags: diabetes, diabetes 2, SGLT2 inhibitor, breast cancers, diabetic medication, liver injury, Food and Drug Administration, bladder

Actos vs. Avandia: An Issue of Safety

Ben Auckland wrote 4 months ago: On June 28, 2010, results of the study of Avandia’s health risk in older adults were published onlin … more →

Tags: actos

New Study Finds Actos as Dangerous as Avandia

Ben Auckland wrote 4 months ago: Avandia For diabetes patients and family members who were comforted by the strict measures implement … more →

Tags: actos, FDA, diabetes drug

Newest Avandia Restriction in Effect- Actos Facing More Criticism for Bladder Cancer Risk2 comments

goldenberglaw wrote 6 months ago: As of Friday, November 18th, rosiglitazone-containing medicines (Avandia, Avandamet, and Avandaryl) … more →

Tags: Dangerous Drugs, regulations, actos, Bladder cancer, FDA, pioglatizone, Recall, rosiglitazone

Pharmaceutical Giant GlaxoSmithKline Agrees To Pay $3 Billion To U.S. Government To Settle Civil And Criminal Investigations Relating To Unlawful Marketing Practices

fraudfighters wrote 6 months ago: On November 3, 2011, the British pharmaceutical company GlaxoSmithKline announced that it has reache … more →

Tags: medicaid fraud, Off-Label Marketing, Settlement, Pharmaceutical, Health Care Fraud, HEALTHCARE FRAUD, GlaxoSmithKline, advair, GSK

Diabetes drugs Byetta, Januvia linked to cancer risk

Drug Recall Watch wrote 8 months ago: A new study has found that diabetes patients taking the drugs Januvia or Byetta may be three times m … more →

Tags: Health Alert!, News, diabetes, Byetta, Pancreatitis, actos, Type 2 Diabetes, Januvia, pancreatic cancer


Have your say. Start a blog.

See our free features →

Related Tags
All →

Follow this tag via RSS